TG-89

• CAT Number: I037179
• CAS Number: 936091-56-4
• Molecular Formula: C26H34N6O3S
• Molecular Weight: 510.65
• Purity: 98%
• Synonyms: TG-89; TG 89; TG89
• Target: Stem Cell/Wnt
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-tert-Butyl-3-[[5-methyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
• InChI: InChI=1S/C26H34N6O3S/c1-19-17-27-25(29-21-8-5-7-20(15-21)18-32-11-13-35-14-12-32)30-24(19)28-22-9-6-10-23(16-22)36(33,34)31-26(2,3)4/h5-10,15-17,31H,11-14,18H2,1-4H3,(H2,27,28,29,30)
• InChIKey: OOSKXASFJFSOBK-UHFFFAOYSA-N
• SMILES: O=S(C1=CC=CC(NC2=NC(NC3=CC=CC(CN4CCOCC4)=C3)=NC=C2C)=C1)(NC(C)(C)C)=O

TG-89(CAT: I037179) is a novel small-molecule inhibitor with potent activity against specific kinases implicated in cancer and inflammatory diseases. It is widely used in preclinical research to study cell signaling pathways, particularly those involved in tumor progression, immune modulation, and inflammatory responses. TG-89 demonstrates high selectivity and efficacy, making it an ideal tool for investigating kinase-driven mechanisms and exploring targeted therapeutic strategies. Suitable for in vitro and in vivo studies, TG-89 supports the advancement of drug discovery and development efforts in oncology and immunology.